Cardiorenalmetabolic

Latest News

Q&A with Sid Patel, MD
Abelacimab Demonstrates Safety and Efficacy for Patients With AFib of All Ages: Sid Patel, MD

April 24th 2025

The continued success of abelacimab throughout the AZALEA-TIMI 71 trials helps draw the drug closer to FDA approval, stated Sid Patel, MD.

One's ZIP code can greatly influence care access | image credit: Syda Productions - stock.adobe.com
"The Barriers Are Real": Antoine Keller, MD, on Geography and Cardiovascular Health

April 18th 2025

Additional research, argued the researchers, should examine the impact of more accessibility to nutritious foods on binge eating. | Image Credit: dizain - stock.adobe.com
Identifying Binge Eating Triggers Among Adults With Food Insecurity

April 12th 2025

Based on the model, over 3 million MACE were projected over the following 10 years, approximately 496,000 of which could be prevented with the use of semaglutide. | Image credit: peter hansen - stock.adobe.com
Semaglutide Use Could Prevent Up to 2 Million MACE in 10 Years, Model Suggests

April 9th 2025

Diabetes concept | Image credit: Sherry Young - stock.adobe.com
GLP-1 RAs, SGLT2 Inhibitors Associated With Reduced MACE, HHF in Patients With Diabetes

April 9th 2025

More News

Hospital building | Image credit: Spiroview Inc. – stock.adobe.com
August 23rd 2024

Postdischarge Mortality Remains Unchanged Despite Advances in Heart Failure Care

Hayden E. Klein
Heart failure mortality rates after hospital discharge have seen little improvement since 2010 among Medicare beneficiaries, with real-world outcomes falling short of clinical trial expectations.
Jose A. Martinez, MD
August 20th 2024

Choosing the Right Treatment Path for Diabetic Macular Edema

Hayden E. Klein
Diabetic macular edema treatment options include anti-vascular endothelial growth factor (anti-VEGF) injections and laser therapy, with patient-specific factors guiding the best approach.
Using Telemedicine to Expand Diabetic Retinopathy Screening
August 16th 2024

Using Telemedicine to Expand Diabetic Retinopathy Screening

Hayden E. Klein
Despite guidelines recommending annual screenings, nearly half of patients with diabetes miss critical eye exams, explains Jose A. Martinez, MD, president and retina specialist at Austin Retina Associates.
Electrocardiogram in hospital surgery operating emergency room | Image credit: totojang1977 – stock.adobe.com
August 15th 2024

Surgery Improves Outcomes for Patients With Atrial Functional Mitral Regurgitation

Hayden E. Klein
A new study found that older patients with atrial functional mitral regurgitation who underwent mitral valve surgery had significantly better outcomes than those who received medical management alone, including lower rates of heart failure hospitalization and death.
Wegovy injections | Image credit: K KStock – stock.adobe.com
August 6th 2024

Rising Costs Lead Insurers to Drop Weight Loss Drug Coverage, Further Increasing Patient Burden

Hayden E. Klein
The growing list of insurers dropping coverage for costly GLP-1 weight loss drugs leaves patients to bear even higher out-of-pocket expenses while still struggling to meet their goals.
AJMC Q&A with Dr Martha Gulati | Background image credit: ipopba – stock.adobe.com
August 2nd 2024

In ASPC President’s Address, Dr Martha Gulati Reflects on Progress and Future Goals in Cardiology

Hayden E. Klein
Martha Gulati, MD, MS, discusses the accomplishments of the American Society of Preventive Cardiology (ASPC) during her presidency and emphasizes the importance of advancing preventive cardiology.
Michael Shapiro, DO, FASPC, Wake Forest University and ASPC president elect
July 31st 2024

ASPC Congress to Highlight Innovations in CVD Prevention

Maggie L. Shaw
In advance of this year’s American Society for Preventive Cardiology (ASPC) 2024 Congress on CVD Prevention, we spoke with ASPC President-Elect Michael Shapiro, DO, FASPC, about the many can't-miss sessions at this year's record-breaking event.
concept of heart issues-ArtemisDiana-stock.adobe.com.jpeg
July 29th 2024

Applying PREVENT Equations May Reduce Statin and Antihypertensive Therapy for 15.8 Million US Adults

Pearl Steinzor
Researchers identify potential reductions in statin and antihypertensive therapy eligibility using Predicting Risk of cardiovascular disease EVENTs (PREVENT) equations.
Patient using a smartwatch | Image Credit: sitthiphong - stock.adobe.com
July 20th 2024

Wearable Devices Heighten Symptom Monitoring, Health Care Visits for Atrial Fibrillation

Brooke McCormick
Patients with atrial fibrillation who use wearable devices, like Apple Watches and FitBits, report higher anxiety levels and increased health care usage than nonusers.
FDA | Image credit: Araki Illustrations – stock.adobe.com
July 18th 2024

FDA Grants Breakthrough Device Designation to ContraBand System to Treat HFrEF

Hayden E. Klein
The catheter-delivered implant uses the right ventricle to support the left, improving left ventricle ejection fraction and helping restore the heart’s normal shape.
US and Japan flags | Image credit: Oleksii – stock.adobe.com
July 18th 2024

Key Differences in Heart Failure Management, Outcomes Between US and Japan

Hayden E. Klein
A new study revealed longer heart failure hospital stays, better 30-day follow-up, and lower mortality rates in Japan compared with the US.
Older woman sleeping with clock on nightstand | Image credit: Pixel-Shot – stock.adobe.com
July 17th 2024

Inconsistent Sleep May Heighten Older Adults’ Risk of Diabetes

Hayden E. Klein
Older adults with the most irregular sleep durations demonstrated a 34% higher risk of developing type 2 diabetes compared with those with the most regular sleep.
Aspirin tablets dissolving in water | Imaged credit: Victor Moussa - stock.adobe.com
July 15th 2024

No Sex Differences Identified in Aspirin Dosing for Secondary Prevention of ASCVD

Pearl Steinzor
No significant differences in efficacy or safety of 2 aspirin doses were found between male and female patients for the secondary prevention of atherosclerotic cardiovascular disease (ASCVD).
Salt and salt shaker | Image credit: Melica – stock.adobe.com
July 15th 2024

Lowering Sodium Intake Reduces AF Risk, but Does Not Improve Heart Failure Outcomes

Hayden E. Klein
New studies say restricting salt intake can reduce the risk of atrial fibrillation (AF) in certain patients, but cannot reduce the risks of morbidity and death in patients with heart failure.
What We’re Reading: Change Cyberattack Exposes Personal Data; Ozempic May Reduce Dementia Risk; Rural Hospitals Shutdown
July 15th 2024

What We’re Reading: Cyberattack Exposes Personal Data; Semaglutide May Reduce Dementia Risk; Rural Hospitals Shutdown

AJMC Staff
Up to one-third of Americans have been affected by data stolen through the Change Healthcare cyberattack; research highlights potential cognitive and psychiatric benefits of semaglutide; over 40 Iowa hospitals have ended their labor and delivery services.
Kathryn Lindley, MD, FACC – Vanderbilt University Medical Center
July 5th 2024

How Vanderbilt's Women's Heart Center Is Bridging the Gender Gap in Heart Health

Hayden E. Klein
Kathryn Lindley, MD, FACC, Vanderbilt University Medical Center, emphasizes the importance of bringing heart health care to patients and meeting them where they are.
Doctor and patient discussing treatment plan | Image credit: Halfpoint – stock.adobe.com
July 5th 2024

GLP-1 Agonists May Reduce Cancer Risk for Patients With Diabetes

Hayden E. Klein
Among patients with type 2 diabetes, glucagon-like peptide 1 (GLP-1) receptor agonists reduced their risk of obesity-related cancers more than insulin did.
counting calories | Image Credit: Andrii Symonenko-stock.adobe.com
June 27th 2024

T1D Management: Carbohydrate Counting With Technology

Kimberly Rath, PharmD
A new study highlights the potential of technology to aid in type 1 diabetes (T1D) management by balancing minimal user input with significant data output to improve user engagement and time in range.
Ian Neeland, MD
June 21st 2024

Obesity Management in 2024: A Look at the CINEMA Program’s Growth and Impact

Hayden E. Klein
The University Hospitals CINEMA program aims to address issues and narrow gaps in obesity management, with a focus on meeting patients where they are and providing them tools for success, says Ian Neeland, MD.
Robert Lustig, MD, MSL
June 21st 2024

Dr Robert Lustig on Pediatric Metabolic Health: “Sugar Is the Alcohol of the Child”

Hayden E. Klein
Robert Lustig, MD, MSL, explains how the US health care industry needs to shift from measuring body mass index and obesity to measuring cardiometabolic health, which affects 93% of Americans, including children.
Ozempic | Image credit: mbruxelle – stock.adobe.com
June 20th 2024

WHO Issues Warning for Fake Semaglutide

Hayden E. Klein
Taking falsified semaglutide (Ozempic; Novo Nordisk) can lead to ineffective treatment due to incorrect dosing, contamination, and the use of unknown ingredients, the World Health Organization (WHO) is warning.
older person with T1D | Image Credit: dorde-stock.adobe.com
June 19th 2024

More People With T1D Are Living Into Old Age

Jared Kaltwasser
A new prevalence study shows more people are living beyond age 65 with type 1 diabetes (T1D).
Age, Insurance Play Major Roles in CGM Use, Says Dr Chase Hendrickson
June 18th 2024

Age, Insurance Play Major Roles in CGM Use, Says Dr Chase Hendrickson

Hayden E. Klein
Patients with diabetes who have private insurance are more likely to be prescribed a continuous glucose monitor (CGM) compared with those with government insurance, says Chase Hendrickson, MD, MPH, Vanderbilt University Medical Center.
Blood vessel | Image credit: Dr_Microbe – stock.adobe.com
June 17th 2024

STRONG-HF Data Suggest Bio-ADM Enhances Heart Failure Prognostic Value

Hayden E. Klein
Patients with the highest biologically active adrenomedullin (bio-ADM) levels at baseline were 114% more likely to die from any cause or be readmitted to the hospital for heart failure within 6 months compared with patients with the lowest levels.
blood sugar control concept | Image Credit: Phruetthiphong-stock.adobe.com
June 16th 2024

AYA With T1D Have Suboptimal Glucose Control

AJMC Contributor
Notably, adolescents and young adults (AYA) living with type 1 diabetes (T1D) who reported more comfort with self-management tended to have worse glycemic control.
Older woman smelling flowers | Image credit: Halfpoint – stock.adobe.com
June 14th 2024

Loss of Smell May Predict Heart Failure Risk

Hayden E. Klein
Adults aged 70 and older were significantly more likely to develop congestive heart failure if they also experienced olfactory impairment.
FDA | Image credit: Araki Illustrations – stock.adobe.com
June 13th 2024

FDA Approves Dapagliflozin for Children With Type 2 Diabetes

Hayden E. Klein
Children aged 10 years and older with type 2 diabetes can now improve their glycemic control with a drug previously only approved for adults.
T1D icon | Image Credit: MQ-Illustrations-stock.adobe.com
June 12th 2024

Gender May Affect Whether, Why Patients With T1D Exercise

Jared Kaltwasser
Men are less likely than women to desire community when exercising, the authors found.
Jeff Levin-Scherz, MD, MBA
June 11th 2024

Dr Jeff Levin-Scherz Addresses Gaps in Obesity Care and Funding Challenges

Hayden E. Klein
Jeff Levin-Scherz, MD, MBA, population health leader at WTW, explains that obesity care in the US is inconsistent and costly, with significant gaps across Medicare, Medicaid, and employer-based insurance.
<1234>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo